McKesson Corporation launched Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer.
Brian Tyler, Chief Executive Officer, McKesson said: “Ontada reflects McKesson’s continued commitment and investment in the oncology community. As one of the largest healthcare companies, McKesson is at the center of care delivery, which provides a unique perspective on the complexities of cancer care and the growing needs among providers and life sciences companies. With the launch of Ontada, we can now build upon our differentiated assets in oncology and deliver innovative solutions that help improve patient outcomes.”
Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities with a leading suite of technologies for oncology clinicians – including the iKnowMed electronic health record system and Clear Value Plus regimen support tool – as well as a connection to a national community oncology network to transform the fight against cancer.
Through its deep connections to oncology practices, Ontada can help expand the reach of therapies with engagement and education opportunities with physicians. The benefits that Ontada can offer to providers are further enhanced, through its strong relationship with McKesson’s The US Oncology Network, as well as other community oncology practices.
Michael Seiden, M.D., PhD, president, The US Oncology Network said: “At The US Oncology Network, we collaborate with practices to leverage evidence-driven care to deliver better patient outcomes. We’re thrilled to have Ontada as a technology partner who shares our vision and will provide us with the tools and insights we need to put patients first.”
